Search clinical trials for: obrutinib, rituximab
Total 3477 results
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Papworth Hospital NHS Foundation TrustCompletedMyocardial Infarction | Inflammation | Ischemic Heart DiseaseUnited Kingdom
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
Swiss Group for Clinical Cancer ResearchCompletedLymphomaSwitzerland, South Africa, Italy, Brazil, North Macedonia, Serbia, Slovakia
-
Stephen Howell, M.D.Genentech, Inc.UnknownProstate CancerUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Follicular Lymphoma or Mantle Cell LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
BiogenTerminated
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation; Cooperative Clinical Trials in Pediatric...CompletedKidney Transplant | Kidney Transplant Recipient | Graft Function/Survival | de Novo HLA Antibodies DevelopmentUnited States
-
Andres J. M. FerreriCompletedOcular Adnexal Mucosa-Associated Lymphoid Tissue LymphomaItaly
-
PfizerDevelopmental Therapeutics ConsortiumTerminatedPreviously Treated PH + CMLSpain, United States, Austria, Sweden, Germany, France, Italy, Norway
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieWithdrawnRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingPrimary Membranous NephropathyChina
-
Beijing Friendship HospitalRecruitingChronic Active Epstein-Barr Virus Infection | Secondary Hemophagocytic LymphohistiocytosisChina
-
New York Medical CollegeRecruitingImmune Thrombocytopenic PurpuraUnited States
-
Cogent Biosciences, Inc.Terminated
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedThrombotic Thrombocytopenic PurpuraUnited States
-
Cogent Biosciences, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
International Extranodal Lymphoma Study Group (IELSG)Withdrawn
-
Ostfold Hospital TrustOslo University Hospital; South-Eastern Regional Health AuthorityCompleted
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
German High-Grade Non-Hodgkin's Lymphoma Study...Deutsche Krebshilfe e.V., Bonn (Germany)CompletedNon-Hodgkin's Lymphoma (NHL)Germany
-
CelltrionCompleted
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLymphomaNew Zealand, United Kingdom, Australia
-
East Carolina UniversityGenentech, Inc.CompletedPulmonary Alveolar Proteinosis | Primary DiseaseUnited States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicSweden
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaGermany
-
Medical University of ViennaTerminated
-
Meirav Kedmi MDJohnson & JohnsonUnknownDiffuse Large B Cell Lymphoma | Recurrent Disease | Refractory Cancer | Primary Mediastinal (Thymic) Large B-cell Lymphoma | Transformed Indolent LymphomaIsrael
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University of BonnPfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsUnknownChronic Myelogenous LeukaemiaGermany
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
Pharmacyclics LLC.CompletedMetastatic Renal Cell Carcinoma | Metastatic Colorectal Adenocarcinoma | Advanced Gastric Adenocarcinoma | Advanced Urothelial CarcinomaUnited States, Korea, Republic of, Spain, United Kingdom
-
CelgeneThe Lymphoma Academic Research OrganisationCompletedFollicular LymphomaJapan, United States
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom